Navigation Links
Reportlinker Adds China Cardiovascular Devices Market Outlook to 2016
Date:6/1/2010

p>

Figure 101: Peripheral Vascular Devices Market, China, Revenue Mix ($m), 2009 145

Figure 102: Peripheral Vascular Devices Market, China, Category Contribution (%), 2009 146

Figure 103: Peripheral Vascular Devices, China, Revenue ($m) by Segment, Historic, 2002-2009 147

Figure 104: Peripheral Vascular Devices, China, Revenue ($m) by Segment, Forecast, 2009-2016 149

Figure 105: Peripheral Vascular Devices, China, Volume (Units) by Segment, Historic, 2002-2009 151

Figure 106: Peripheral Vascular Devices, China, Volume (Units) by Segment, Forecast, 2009-2016 153

Figure 107: Peripheral Vascular Devices, China, Company Share (%), 2009 157

Figure 108: Boston Scientific Corporation, Company Share (%),China Cardiovascular Devices Market, 2009 159

Figure 109: Medtronic, Inc., Company Share (%),China Cardiovascular Devices Market, 2009 160

Figure 110: Cordis Corporation, Company Share (%),China Cardiovascular Devices Market, 2009 161

Figure 111: St. Jude Medical, Inc., Company Share (%),China Cardiovascular Devices Market, 2009 162

Figure 112: Abbott Laboratories, Company Share (%),China Cardiovascular Devices Market, 2009 163

Figure 113: Terumo Corporation, Company Share (%),China Cardiovascular Devices Market, 2009 165

Figure 114: Biosense Webster, Inc., Company Share (%),China Cardiovascular Devices Market, 2
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine technology :

1. Reportlinker Adds Medical Device Distributors - Europe
2. Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
3. Reportlinker Adds Global Pulmonary Drug Delivery Technologies industry
4. Reportlinker Adds Global HIV Drugs industry
5. Reportlinker Adds Ophthalmic Therapeutic Drugs: Technologies and Global Markets
6. Reportlinker Adds Antifungal Drugs: Technologies and Global Markets
7. Reportlinker Adds The World Anesthesia Drug Market
8. Reportlinker Adds Stakeholder Opinions: Cardiovascular and Metabolic Generics - Generics continue to gain prominence
9. Reportlinker Adds Global Pain Relieving Drug Market Analysis 2010-2025
10. Reportlinker Adds The Outlook for Pharmaceuticals in Western Europe
11. Reportlinker Adds Atherosclerosis Or Coronary Artery Disease (CAD) - Drug Pipeline Analysis and Market Forecasts to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)...  Edwards Lifesciences Corporation (NYSE: EW ), the ... hemodynamic monitoring, is scheduled to present at the 10th ... Boston in Boston, Massachusetts on ... Mussallem , Edwards Lifesciences, chief executive officer, is scheduled ... discussion with conference attendees at 10:10 a.m. PDT (1:10 ...
(Date:9/1/2015)... Sept. 1, 2015  Results from an interim analysis ... that 5g of idarucizumab enabled emergency surgery to ... treated with dabigatran (Pradaxa ® dabigatran etexilate ... effect of dabigatran enabled patients to be urgently ... of 1.7 hours between administration of idarucizumab and ...
(Date:9/1/2015)... BAKERSFIELD, Calif. , Sept. 1, 2015 /PRNewswire/ ... Chronic Care Management (CCM) and Drug Adherence m ... monitoring help automate the process of non face-to-face ... "With this new release of our apps, ... care management services along with our ONCHIT certified ...
Breaking Medicine Technology:New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 3New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 4New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 6New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 7New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 8New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 9SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2
... VION,PHARMACEUTICALS, INC. (Nasdaq: VION ) today announced ... its lead anticancer agent Cloretazine(R),(VNP40101M) in elderly patients with ... at the 44th Annual Meeting of the,American Society of ... data were presented in 85 evaluable patients. The median,age ...
... June 2 Physicians affiliated with the US,Oncology Research ... the 44th Annual Meeting of the American Society of ... in Chicago., Dr. Joyce O,Shaughnessy of Texas Oncology-Baylor ... gave an oral presentation on,findings from a randomized Phase ...
Cached Medicine Technology:Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 2Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 3Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 4US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 2US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 3US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 4US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings 5
(Date:9/2/2015)... ... September 02, 2015 , ... Canopy ... been named to the Inc. 5000 List, an independent ranking of the ... for 34 years, and this achievement puts Canopy in rarefied company. Over the ...
(Date:9/2/2015)... ... September 02, 2015 , ... Traveling to the Caribbean ... array of magnificent flora and fauna. , Lifestyle Holidays Vacation Club knows ... To help make travelers experience that much better, Lifestyle Holidays Vacation Club has put ...
(Date:9/1/2015)... ... September 01, 2015 , ... September is National Prostate Cancer ... affects more than 233,000 men each year in the United States. , Prostate cancer ... non-skin cancer in America, affecting 1 in 7 men. One new case occurs every ...
(Date:9/1/2015)... ... ... Earth Brands, ( http://www.earthbrands.com ) a comfort-meets-fashion women’s footwear ... an Earth Brand shoe will be given an opportunity to plant a tree ... nonprofit dedicated to planting more trees. Earth Brands products represent contemporary designs and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Stress comes ... created from everyday life changes can lead to very serious, life-altering events. Fortunately ... coping with stress. Herbal supplement manufacturer MediHerb has coupled therapeutic doses ...
Breaking Medicine News(10 mins):Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 2Health News:Earth Brands Footwear Partners with Trees for the Future for Launch of Fall Collection: Buy Shoes, Plant a Tree 3Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 2Health News:MediHerb Launches New Herbal Supplement to Help with the Challenges of Everyday Life 3
... San Diego, California, May 19, 2008 NPS Pharmaceuticals, ... 3 data at the annual Digestive Disease Week (DDW) ... may reduce dependence upon parenteral nutrition (PN) in patients ... (SBS). , The Phase 3 study evaluated ...
... counties - Los Angeles, Alameda, Contra Costa, San Mateo, San Francisco, ... ... Procedures, WOODLAND HILLS, Calif., May 19 ... initiative into California. Now, approximately 1.8 million of,Anthem Blue Cross members in ...
... of developing reliable genetic tests to guide lung cancer ... University recently evaluated the ability of five high-risk genetic ... would recur in patients whose non-small cell lung cancer ... their findings at the American Thoracic Societys 2008 International ...
... 19 Towards the Electronic,Patient Record (TEPR) ... terminology,announced today its next-generation interface terminology delivery ... access to all of,IMO,s terminology knowledge sources. ... optimized for millisecond response times in a ...
... Million Verdict Upheld Against Mesothelioma Victim,s Former Employers, ... fifteen months after,winning a $3.2 million verdict against ... Constructors, Inc. on behalf of,mesothelioma victim Ray Rando, ... been affirmed by the Louisiana First Circuit Court ...
... surgeon at the University of Liverpool has performed a groundbreaking ... more commonly seen in dogs. , The three year-old chimp ... year and now lives in a chimpanzee reserve supported by ... and had difficulty walking because a bone in her forearm ...
Cached Medicine News:Health News:Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome 2Health News:Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome 3Health News:Phase 3 GATTEX results presented at DDW highlight potential new treatment in short bowel syndrome 4Health News:Anthem Blue Cross Introduces Industry's Most Comprehensive Transparency Initiative to California 2Health News:Anthem Blue Cross Introduces Industry's Most Comprehensive Transparency Initiative to California 3Health News:Will lung cancer recur? A genetic test may provide the answer 2Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 2Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 3Health News:Intelligent Medical Objects (IMO), Inc. announces the General Availability of Its Terminology Portal Service for EMR/EHR and Charge-Capture Applications 4Health News:Asbestos Verdict Upheld by Louisiana Court of Appeal, Announces Baron & Budd 2Health News:Surgeon operates to rescue chimp with rare deformity 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: